Published in J Biol Chem on February 19, 2010
The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy (2013) 1.37
Comparative pathogenomics reveals horizontally acquired novel virulence genes in fungi infecting cereal hosts. PLoS Pathog (2012) 1.34
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. BMC Cancer (2012) 0.94
Purification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytes. J Biol Chem (2011) 0.79
Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions. PLoS One (2015) 0.78
Characterization of a novel oxidase from Thelonectria discophora SANK 18292 involved in nectrisine biosynthesis. AMB Express (2016) 0.77
Xenobiotic Metabolism and Gut Microbiomes. PLoS One (2016) 0.75
Identification of activating enzymes of a novel FBPase inhibitor prodrug, CS-917. Pharmacol Res Perspect (2015) 0.75
The Pfam protein families database. Nucleic Acids Res (2007) 30.53
The alpha/beta hydrolase fold. Protein Eng (1992) 9.94
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16
Chemical structure and biodegradability of halogenated aromatic compounds. Conversion of chlorinated muconic acids into maleoylacetic acid. Biochem J (1980) 3.66
MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2006) 3.56
The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol (1994) 1.97
Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci (2006) 1.85
Structure, function and regulation of carboxylesterases. Chem Biol Interact (2006) 1.80
Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab Pharmacokinet (2006) 1.75
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules (2008) 1.52
Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.50
Lessons learned from marketed and investigational prodrugs. J Med Chem (2004) 1.43
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr Drug Metab (2003) 1.34
Alpha/beta hydrolase fold: an update. Protein Pept Lett (2009) 1.26
Refined structure of dienelactone hydrolase at 1.8 A. J Mol Biol (1990) 1.23
Dienelactone hydrolase from Pseudomonas sp. strain B13. J Bacteriol (1987) 1.20
Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase. J Biol Chem (2003) 1.19
Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs (2008) 1.09
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radic Biol Med (2004) 1.09
Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase. J Biol Chem (2008) 1.04
The cholinesterases. J Biol Chem (1991) 1.03
X-ray crystallographic structure of dienelactone hydrolase at 2.8 A. J Mol Biol (1988) 1.03
Faropenem: review of a new oral penem. Expert Rev Anti Infect Ther (2007) 0.98
The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. J Hypertens Suppl (2001) 0.97
Prodrug research: futile or fertile? Biochem Pharmacol (2004) 0.97
Thiol protease-like active site found in the enzyme dienelactone hydrolase: localization using biochemical, genetic, and structural tools. Proteins (1991) 0.95
Catalysis by dienelactone hydrolase: a variation on the protease mechanism. Proteins (1993) 0.92
Amlodipine/ARB fixed-dose combinations for the treatment of hypertension: focus on amlodipine/olmesartan combination. Drugs Today (Barc) (2008) 0.87
Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos (1998) 0.86
A theoretical study of substrate-induced activation of dienelactone hydrolase. Protein Eng (1995) 0.85
Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug Metab Dispos (2005) 0.81
Candesartan cilexetil: an update of its use in essential hypertension. Drugs (2002) 0.80
3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl esters. J Med Chem (1984) 0.80
Studies on prodrugs. II. Preparation and characterization of (5-substituted 2-oxo-1,3-dioxolen-4-yl)methyl esters of ampicillin. Chem Pharm Bull (Tokyo) (1984) 0.79
Rapid method for the quantification of amoxicillin and its major metabolites in pig tissues by liquid chromatography-tandem mass spectrometry with emphasis on stability issues. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.78
Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan. J Renin Angiotensin Aldosterone Syst (2009) 0.78
Toxicological implications of esterases--from molecular structures to functions. Toxicol Appl Pharmacol (2005) 0.77
Pharmacokinetic study of lenampicillin (KBT-1585) in healthy volunteers. Antimicrob Agents Chemother (1986) 0.77
Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature (2009) 4.98
Electrostatic basis for enzyme catalysis. Chem Rev (2006) 4.35
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos (2010) 3.06
Modeling electrostatic effects in proteins. Biochim Biophys Acta (2006) 2.91
Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance. World Neurosurg (2011) 2.04
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther (2003) 1.84
Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem (2003) 1.81
Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. J Biol Chem (2010) 1.61
Risk of aneurysmal rupture: the importance of neck orifice positioning-assessment using computational flow simulation. Neurosurgery (2008) 1.61
A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J Biol Chem (2007) 1.59
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature (2016) 1.52
Regulation of meiotic recombination via Mek1-mediated Rad54 phosphorylation. Mol Cell (2009) 1.51
Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients. Circ J (2010) 1.49
Exploring the origin of the ion selectivity of the KcsA potassium channel. Proteins (2003) 1.43
Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol (2009) 1.41
Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med (2013) 1.41
Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. J Pharm Biomed Anal (2008) 1.37
Apparent NAC effect in chorismate mutase reflects electrostatic transition state stabilization. J Am Chem Soc (2003) 1.33
What are the roles of substrate-assisted catalysis and proximity effects in peptide bond formation by the ribosome? Biochemistry (2005) 1.23
Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450. Drug Metab Dispos (2006) 1.20
OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Drug Metab Dispos (2006) 1.19
Structural analysis of obscurin gene in hypertrophic cardiomyopathy. Biochem Biophys Res Commun (2007) 1.19
A site-specific, multiplexed kinase activity assay using stable-isotope dilution and high-resolution mass spectrometry. Proc Natl Acad Sci U S A (2009) 1.17
p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. J Biol Chem (2009) 1.16
Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem (2005) 1.15
Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun (2005) 1.14
G2A as a receptor for oxidized free fatty acids. Prostaglandins Other Lipid Mediat (2008) 1.10
Edoxaban transport via P-glycoprotein is a key factor for the drug's disposition. Drug Metab Dispos (2014) 1.06
Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium. FEMS Immunol Med Microbiol (2007) 1.06
A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel. Drug Metab Dispos (2009) 1.05
CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract. Antimicrob Agents Chemother (2009) 1.04
The disposition of prasugrel, a novel thienopyridine, in humans. Drug Metab Dispos (2007) 1.04
Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry. Biomed Chromatogr (2007) 1.03
Stereoselective metabolism of prasugrel in humans using a novel chiral liquid chromatography-tandem mass spectrometry method. Drug Metab Dispos (2007) 1.01
G2A plays proinflammatory roles in human keratinocytes under oxidative stress as a receptor for 9-hydroxyoctadecadienoic acid. J Invest Dermatol (2007) 1.01
Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J Biol Chem (2002) 1.00
Brain insulin impairs amyloid-beta(1-40) clearance from the brain. J Neurosci (2004) 1.00
HA-33 facilitates transport of the serotype D botulinum toxin across a rat intestinal epithelial cell monolayer. FEMS Immunol Med Microbiol (2011) 0.99
CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. J Biol Chem (2008) 0.99
A study of upper extremity training for patients with stroke using a virtual environment system. J Phys Ther Sci (2013) 0.98
Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers. Antimicrob Agents Chemother (2006) 0.98
Humanization of excretory pathway in chimeric mice with humanized liver. Toxicol Sci (2007) 0.98
Metabolic syndrome among pre- and post-menopausal rural women in Bangladesh: result from a population-based study. BMC Res Notes (2013) 0.96
Mass spectrometric analysis of type 1 inositol 1,4,5-trisphosphate receptor ubiquitination. J Biol Chem (2008) 0.95
A case of giant common carotid artery aneurysm associated with vascular Behçet disease: successfully treated with a covered stent. Surg Neurol (2008) 0.95
Thioesterase activity and subcellular localization of acylprotein thioesterase 1/lysophospholipase 1. Biochim Biophys Acta (2009) 0.94
A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanism. J Biol Chem (2010) 0.93
Covalent binding and tissue distribution/retention assessment of drugs associated with idiosyncratic drug toxicity. Drug Metab Dispos (2008) 0.93
Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum Mol Genet (2008) 0.91
A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding. Drug Metab Dispos (2009) 0.91
Involvement of reactive oxygen species in sonodynamically induced apoptosis using a novel porphyrin derivative. Theranostics (2012) 0.91
Prevalence of metabolic syndrome among rural Bangladeshi women. Diabetes Res Clin Pract (2011) 0.91
Magnetic resonance fluid dynamics for intracranial aneurysms--comparison with computed fluid dynamics. Acta Neurochir (Wien) (2012) 0.91
Association of age at menarche with metabolic syndrome and its components in rural Bangladeshi women. Nutr Metab (Lond) (2012) 0.90
A novel pressure sensor with an optical system for coil embolization of intracranial aneurysms. Laboratory investigation. J Neurosurg (2009) 0.89
Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry. Chem Res Toxicol (2007) 0.89
Role of domains within the autotransporter Hbp/Tsh. Acta Crystallogr D Biol Crystallogr (2010) 0.89
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel. Drug Metab Dispos (2008) 0.89
Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide. Drug Metab Dispos (2010) 0.88
Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. J Allergy Clin Immunol (2003) 0.88
Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats. Drug Metab Dispos (2011) 0.88
Inhibitory effects of angiotensin receptor blockers on CYP2C9 activity in human liver microsomes. Drug Metab Pharmacokinet (2007) 0.88
Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family. Toxicol Sci (2010) 0.88
Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates of human renal transporters. Drug Metab Pharmacokinet (2007) 0.87
Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine γ-lyase, an animal model of cystathioninuria. Free Radic Biol Med (2012) 0.87
Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. Drug Metab Pharmacokinet (2008) 0.87
Sp1 is a co-activator with Ets-1, and Net is an important repressor of the transcription of CTP:phosphocholine cytidylyltransferase alpha. J Biol Chem (2005) 0.87
Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J Pharmacol Exp Ther (2003) 0.87
Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings. J Nucl Cardiol (2011) 0.86
11C-methionine PET of acute myocardial infarction. J Nucl Med (2009) 0.86
Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals. Antimicrob Agents Chemother (2006) 0.86
Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes. Drug Metab Dispos (2008) 0.86
Stunned myocardium in transient left ventricular apical ballooning: a serial study of dual I-123 BMIPP and Tl-201 SPECT. J Nucl Cardiol (2008) 0.86
Tissue distribution of humanized anti-human Fas monoclonal antibody (R-125224) based on fas antigen-antibody reaction in collagen-induced arthritis monkeys. Life Sci (2007) 0.85
The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling. Pharm Res (2008) 0.85
Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data. Drug Metab Pharmacokinet (2011) 0.85
Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes. Life Sci (2009) 0.84
Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging. Am J Nucl Med Mol Imaging (2013) 0.84
Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells. Vet Microbiol (2009) 0.84
Usefulness of three-dimensional digital subtraction angiography in endovascular treatment of a spinal dural arteriovenous fistula. J Neurosurg Spine (2008) 0.84
Detection of G protein-coupled receptor-mediated cellular response involved in cytoskeletal rearrangement using surface plasmon resonance. Biosens Bioelectron (2009) 0.84